Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations

References

• MathesonAJJarvisBLansoprazole: an update of its place in the management of acid-related disordersDrugs2001611801183311693467
   PubMed Web of Science ®Google Scholar
• ZhangDYangMLiuMPharmacokinetics of lansoprazole and its main metabolites after single intravenous doses in healthy Chinese subjectsXenobiotica2012421156116222612620
   PubMed Web of Science ®Google Scholar
• BaldiFLansoprazole oro-dispersible tablet – pharmacokinetics and therapeutic use in acid-related disordersDrugs200565101419142615977971
   PubMed Web of Science ®Google Scholar
• StedmanCABarclayMLReview article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitorsAliment Pharmacol Ther20001496397810930890
   PubMed Web of Science ®Google Scholar
• HeCHuYYinLTangCYinCEffects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticlesBiomaterials2010313657366620138662
   PubMed Web of Science ®Google Scholar
• HornJRHowdenCWReview article: similarities and differences among delayed-release proton-pump inhibitor formulationsAliment Pharmacol Ther200522202416303033
   PubMed Web of Science ®Google Scholar
• KatzPOKochFKBallardEDComparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptomsAliment Pharmacol Ther20072519720517229243
   PubMed Web of Science ®Google Scholar
• WuZMZhouLYGuoXDHP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulinInt J Pharm20124251822248666
   PubMed Web of Science ®Google Scholar
• AdibkiaKJavadzadehYDastmalchiSMohammadiGNiriFKAlaei-BeiramiMNaproxen-Eudragit RS100 nanoparticles: preparation and physicochemical characterizationColloids Surf B Biointerfaces20118315515921130612
   PubMed Web of Science ®Google Scholar
• DevarajanPVSonavaneGSPreparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriersDrug Dev Ind Pharm20073310111117454041
   PubMed Web of Science ®Google Scholar
• DaiJNagaiTWangXZhangTMengMZhangQpH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine AInt J Pharm200428022924015265562
   PubMed Web of Science ®Google Scholar
• WangHJiaYHuWJiangHZhangJZhangLEffect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcuminPharm Dev Technol20131869470022676257
   PubMed Web of Science ®Google Scholar
• CetinMAtilaASahiSVuralIPreparation and characterization of metformin hydrochloride loaded-Eudragit®RSPO and Eudragit®RSPO/PLGA nanoparticlesPharm Dev Technol20131857057621864098
   PubMed Web of Science ®Google Scholar
• CollnotEMAliHLehrCMNano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosaJ Control Release201216123524622306429
   PubMed Web of Science ®Google Scholar
• HassaniSPellequerYLamprechtASelective adhesion of nanoparticles to inflamed tissue in gastric ulcersPharm Res2009261149115419205850
   PubMed Web of Science ®Google Scholar
• KorsmeyerRWGurnyRDoelkerEBuriPPeppasNAMechanisms of solute release from porous hydrophilic polymersInt J Pharm1983152535
   Web of Science ®Google Scholar
• AlgieriCDrioliEDonatoLDevelopment of mixed matrix membranes for controlled release of ibuprofenJ Appl Polym Sci2013128754760
   Web of Science ®Google Scholar
• AlaiMSLinWJA novel nanoparticulate system for sustained delivery of acid-labile lansoprazoleColloids Surf B Biointerfaces201311145345923867305
   PubMed Web of Science ®Google Scholar
• RaffinRPColomeLMPohlmannARGuterresSSPreparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticlesEur J Pharm Biopharm20066319820416531029
   PubMed Web of Science ®Google Scholar
• ItoYAraiHUchinoKIwasakiKShibataNTakadaKEffect of adsorbents on the absorption of lansoprazole with surfactantInt J Pharm2005289697715652200
   PubMed Web of Science ®Google Scholar
• AlaiMSLinWJNovel lansoprazole-loaded nanoparticles for the treatment of gastric acid secretion-related ulcers: in vitro and in vivo pharmacokinetic pharmacodynamic evaluationAAPS J20141636137224519468
   PubMed Web of Science ®Google Scholar
• JohnsonCECoberMPLudwigJLStability of partial doses of omeprazole-sodium bicarbonate oral suspensionAnn Pharmacother2007411954196117956960
   PubMed Web of Science ®Google Scholar
• AlaiMSLinWJA novel once daily microparticulate dosage form comprising lansoprazole to prevent nocturnal acid breakthrough in the case of gastro-esophageal reflux disease: preparation, pharmacokinetic and pharmacodynamic evaluationJ Microencapsul20133051952923294453
   PubMed Web of Science ®Google Scholar
• SunWZLinWJAlaiMSPreparation of microparticles for acid-labile lansoprazole by solvent evaporation method combined with a spray drying processJ Food Drug Anal201220438445
   Web of Science ®Google Scholar
• DasSSureshPKDesmukhRDesign of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug deliveryNanomedicine2010631832319800990
   PubMed Web of Science ®Google Scholar
• IbrahimHKEl-LeithyISMakkyAAMucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapyMol Pharm2010757658520163167
   PubMed Web of Science ®Google Scholar
• GarciaXEscribanoEDomenechJQueraltJFreixesJIn vitro characterization and in vivo analgesic and anti-allodynic activity of PLGA-bupivacaine nanoparticlesJ Nanopart Res20111322132223
   Web of Science ®Google Scholar
• SunBRanganathanBFengSSMultifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancerBiomaterials20082947548617953985
   PubMed Web of Science ®Google Scholar
• WinKYFengSSEffects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials2005262713272215585275
   PubMed Web of Science ®Google Scholar
• DongYFengSSPoly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugsBiomaterials2005266068607615894372
   PubMed Web of Science ®Google Scholar
• VlaseLPopaANeagMMunteanDLeucutaSEEffect of fluoxetine on the pharmacokinetics of lansoprazole: a two-treatment period study in healthy male subjectsClin Drug Investig201131727733
   PubMed Web of Science ®Google Scholar
• SongMGaoXHangTJWenADPharmacokinetic properties of lansoprazole (30-mg enteric-coated capsules) and its metabolites: a single-dose, open-label study in healthy Chinese male subjectsCurr Ther Res Clin Exp20097022823924683233
   PubMed Web of Science ®Google Scholar
• StefaničMLocatelliIVrečerFSeverTMrharABogatajMThe influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlationEur J Pharm Biopharm20128237638222884655
   PubMed Web of Science ®Google Scholar
• CapursoGMarignaniMAttiliaFLansoprazole-induced microscopic colitis: an increasing problem? Results of a prospecive case-series and systematic review of the literatureDig Liver Dis20114338038521195042
   PubMedGoogle Scholar
• TarnawskiASCellular and molecular mechanisms of gastrointestinal ulcer healingDig Dis Sci200550S24S3316184417
   PubMed Web of Science ®Google Scholar